Brian Stoltz is an entrepreneur and Professor of Chemistry at Caltech. He is a leading expert In chemical synthesis and has a focus on innovating processes to synthesize unique molecules with novel structural, biological, and physical properties. He is the co-founder of 1200 Pharma and DnaTwo. He has had an academic background at Yale and Harvard.